Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rani Therapeutics Holdings (RANI) Receivables (2024 - 2025)

Rani Therapeutics Holdings (RANI) has 2 years of Receivables data on record, last reported at $600000.0 in Q1 2025.

  • For Q1 2025, Receivables changed N/A year-over-year to $600000.0; the TTM value through Mar 2025 reached $600000.0, changed N/A, while the annual FY2024 figure was $428000.0, N/A changed from the prior year.
  • Receivables reached $600000.0 in Q1 2025 per RANI's latest filing, up from $428000.0 in the prior quarter.
  • Across five years, Receivables topped out at $600000.0 in Q1 2025 and bottomed at $428000.0 in Q4 2024.